SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive. 1987

P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
Istituto di Clinica Ostetrica e Ginecologica dell'Università degli Studi di Ferrara.

A triphasic oral contraceptive Trigynon (Schering) or Triphasil (Wyeth) was administered to 13 anovulatory women with hyperandrogenism, enlarged polycystic ovaries and reversal of LH/FSH ratio. After three months of treatment total Testosterone, Androstenedione and 17-OH-Progesterone levels significantly decreased while SHBG significantly increased. Reduction of hair growth and improvement of acne were noted. Side effects were minimal.

UI MeSH Term Description Entries
D009644 Norgestrel A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis. 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-,DL-Norgestrel,Neogest,Ovrette,Postinor,Wy-3707,DL Norgestrel,Wy 3707,Wy3707
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D003280 Contraceptives, Oral, Synthetic Oral contraceptives which owe their effectiveness to synthetic preparations.
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006908 Hydroxyprogesterones Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione

Related Publications

P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
February 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
March 1983, Acta endocrinologica,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
December 1974, Folia endocrinologica,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
January 1980, The Journal of nuclear medicine and allied sciences,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
October 2022, Steroids,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
January 2013, European review for medical and pharmacological sciences,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
July 1988, Contraception,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
January 1975, Acta obstetricia et gynecologica Scandinavica,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
August 1984, Journal of endocrinological investigation,
P Negri, and G Agnello, and F Borghesani, and L Tomain, and N Minisci, and G D'Errico, and A R Cavallini
October 1975, Journal of reproduction and fertility,
Copied contents to your clipboard!